MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland
· Delayed Price · Currency is CHF 0.560
-0.088 (-13.58%)
At close: Mar 6, 2026
MindMaze Therapeutics Holding Company Description
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
MindMaze Therapeutics Holding SA
| Country | Switzerland |
| Founded | 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Alexandre Capet |
Contact Details
Address: Chemin de Roseneck 5 Lausanne, 1006 Switzerland | |
| Phone | 41 21 552 08 01 |
| Website | mindmazetherapeutics.com |
Stock Details
| Ticker Symbol | MMTX |
| Exchange | SIX Swiss Exchange |
| Reporting Currency | CHF |
| ISIN Number | CH1251125998 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Alexandre Capet | Chief Executive Officer |
| Jeremy Meinen CPA | Chief Financial Officer |
| Frédéric Condolo | Chief Technology Officer |
| Paolo Galfetti | Chief Business Officer |